NMN for Obesity: What the Evidence Actually Shows
What is Obesity?
Obesity is excess body fat that raises the risk of diabetes, heart disease, joint problems and certain cancers. It is defined in Malaysia as BMI of 27.5 or above.
NMN relevance: the published evidence
NMN does not cause weight loss in any human trial. Mouse studies (Mills 2016) showed metabolic improvements without major weight change. Yoshino 2021 reported no weight effect at 250 mg/day. NMN is not a weight-loss agent and should not be marketed as one.
Questions to ask before supplementing
No dose validated for weight loss.
Contraindications and red flags
Do not delay evidence-based weight management (diet, exercise, GLP-1 agonists, bariatric surgery) by relying on NMN.
Bottom line for Malaysian patients
NMN is not registered with NPRA as a treatment for any specific condition; it is sold as a general health supplement. If you have obesity, use this page as a question list for a registered medical practitioner before adding NMN to existing therapy. Read our safety guide for full red-flag context.
Related conditions
- Type 2 Diabetes - Type 2 diabetes is a chronic condition where the body becomes resistant to insulin and blood glucose...
- Metabolic Syndrome - Metabolic syndrome is a cluster of conditions including central obesity, high blood pressure, dyslip...
- Non-Alcoholic Fatty Liver Disease - NAFLD is fat accumulation in the liver unrelated to alcohol, often tied to obesity and insulin resis...
- Insulin Resistance - Insulin resistance is when muscle, fat and liver cells respond poorly to insulin, forcing the pancre...